Medicus Pharma Ltd. (MDCX) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Medicus Pharma Ltd. is a clinical-stage pharmaceutical company focused on developing and commercializing innovative therapies for unmet medical needs, with an initial focus on dermatological conditions. They are developing a novel microneedle patch technology for targeted drug delivery.
No case yet. It builds on the next filing, report or 13F period.
tall tick = annual report · 1 on record
Medicus Pharma Ltd. has no measured co-movers clearing our correlation floor, so only its SEC classification is shown.
SIC 2834, Pharmaceutical Preparations, from each company's own filings. Largest first.
MDCX (Medicus Pharma Ltd.) has 0 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.
High 0.18 at 3:30 pm ET, low 0.17 at 10:00 am ET.
Medicus Pharma Ltd.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
21 managers report a position worth $1.2M between them, and 3 of them hold 80% of it.